[1] van GASTEL M D,MEIJER E,SCHEVEN L E,et al.Modifiable factors associated with copeptin concentration:a general population cohort[J].Am J Kidney Dis,2014,65(5):719-727.
[2] GRAUGAARDJENSEN C,HVISTENDAHL G M,FROKIAER J,et al.Urinary concentration does not exclusively rely on plasma vasopressin.A study between genders.Gender and diurnal urine regulation[J].Acta Physiol,2015,212(1):97-105.
[3] MORGENTHALER N G,MVLLER B,STRUCK J,et al.Copeptin,a stable peptide of the arginine vasopressin precursor,is elevated in hemorrhagic and septic shock[J].Shock,2007,28(2):219-26.
[4] BALANESCU S,KOPP P,GASKILL M B,et al.Correlation of plasma copeptin and vasopressin concentrations in hypo-,iso-,and hyperosmolar states[J].J Clin Endocrinol Metab,2011,96(4):1046.
[5] REINSTADLER S J,KLUG G,FEISTRITZER H J,et al.Copeptin testing in acute myocardial infarction:ready for routine use?[J].Dis Markers,2015,2015:1-9.
[6] ARBIT B,SHARMA S,CLOPTON P,et al.Influence of gender and copeptin levels on clinical outcomes in patients with acute heart failure[J].J Card Fail,2016,22(8):S29-S29.
[7] SLAGMAN A,SEARLE J,MVLLER C,et al.Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction[J].Clin Chem,2015,61(10):1273-1282.
[8] MÖCKEL M,SEARLE J,HAMM C,et al.Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome(ACS):a randomized,controlled clinical process study[J].Eur Heart J,2015,36(6):369.
[9] GANDHI P U,JANUZZI J L.Can copeptin emerge from the growing shadow of the troponins?[J].Eur Heart J,2015,36(6):333-336.
[10] 李伟宁,魏殿军,宁莉.和肽素与肌钙蛋白联合检测在急性心肌梗死期诊断中的应用价值[J].天津医药,2015,43(11):1319-1322.
[11] TASEVSKA I,ENHÖRNING S,PERSSON M,et al.Copeptin predicts coronary artery disease cardiovascular and total mortality[J].Heart,2016,102(2):127-132.
[12] SCHURTZ G,LAMBLIN N,BAUTERS C,et al.Copeptin in acute coronary syndromes and heart failure management:State of the art and future directions[J].Arch Cardiovasc Dis,2015,108(6-7):398.
[13] HAGE C,LUND L H,DONAL E,et al.Original research article:Copeptin in patients with heart failure and preserved ejection fraction:a report from the prospective KaRen-study[J].Open Heart,2015,2(1):e000260.
[14] POZSONYI Z,FÖRHÉCZ Z,GOMBOS T,et al.Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction[J].Heart Lung Circ,2015,24(4):359-367.
[15] 马红红,马波江.血浆和肽素NT-proBNP浓度对慢性心衰患者生存状况的评估效果[J].河北医学,2015(8):1411-1414.
[16] 徐守阳.急性脑出血患者血浆NT-proBNP与和肽素水平的变化及临床意义[J].承德医学院学报,2017,34(3):211-213.
[17] 李运平,余国峰,戴伟民,等.急性脑出血患者血浆NT-pro BNP及和肽素与病情严重程度及脑出血量的相关性[J].中国现代医生,2017,55(16):7-9.
[18] ZHANG R,LIU J,ZHANG Y,et al.Association between circulating copeptin level and mortality risk in patients with intracerebral hemorrhage:a systemic review and Meta-analysis[J].Mol Neurobiol,2016,54(1):1-6.
[19] BATTISTA S,AUDISIO U,GALLUZZO C,et al.Assessment of diagnostic and prognostic role of copeptin in the clinical setting of sepsis[J].Biomed Res Int,2016,2016:1-7.
[20] WROTEK A,JACKOWSKA T,PAWLIK K.Sodium and copeptin levels in children with community acquired pneumonia[J].Adv Exp Med Biol,2015,835:31.
[21] VIASUS D,DEL R G,SIMONETTI A F,et al.Biomarkers for predicting short-term mortality in community-acquired pneumonia:A systematic review and meta-analysis[J].J Infect,2016,72(3):273-282.
[22] 杨晶晶,杨江江.达托霉素对MRSA致脓毒血症患者血清和肽素与降钙素原水平的影响[J].中国生化药物杂志,2017,37(1):203-206. |
